Anti-aging biotech Elevian raises $15M as it looks to the clinic

Early-stage biotech Elevian has raised $15 million as it looks to target multiple age-related diseases. The Allston, Massachusetts-based company said the small raise would help its preclinical work …
( read original story …)


Advertisement